FDA OKs Medtronic's heart failure ICD (implantable cardioverter defibrillator) device
This article was originally published in Clinica
Executive Summary
The US FDA has approved Medtronic's implantable device that combines cardiac resynchronisation therapy with a defibrillator to treat high-risk heart failure (HF) patients.